High Impact Factor Publications

Publications in high impact factor journals are an important measure of research output and productivity. Below are some publications from journals with impact factors of seven or higher. Faculty member names are indicated in bold font.

2010 - 2009 - 2008

2010

  1. Gil-Mohapel J, Boehme F, Kainer L, Christie BR. 2010. Hippocampal cell loss and neurogenesis after fetal alcohol exposure: Insights from different rodent models. Brain Res Rev.
  2. Conner J., Franks K, Titterness AK, Russell K, Merrill D, Sejnowski T, Christie BR, Tuszynski M. 2010. NGF is essential for hippocampal synaptic plasticity and learning. Journal of Neuroscience. 29(35):10883-9.
  3. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM. 2010. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J. Neurosci.30:7295-7506.
  4. Phenix C, Rempel BP, Colobong K, Doudet DJ, Adam MJ, Clarke LA, Withers SG. 2010. Noninvasive Imaging of replacement therapy in vivo using PET: proof of concept for Gaucher Disease. PNAS 107:10842:10847.
  5. Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. 2010. Resistance training and executive functions: A 12-month randomized controlled trial. Archives of Internal Medicine. 170:170-178.
  6. Durstewitz, D, Vittoz, NM, Floresco SB & Seamans JK. 2010. Abrupt transitions between neural ensemble states in prefrontal cortex accompany behavioral transitions among rules. Neuron 66(3):438-48.
  7. Chen SX, Tari PK, She K, and Haas K. 2010. Cell adhesion molecule contribution to synaptotropic dendritogenesis: NRX-NLG stabilize growth through activity-independent and dependent mechanisms in vivo. Neuron.
  8. Milnerwood AJ, Gladding CM, Pouladi, MA, Kaufman, AM, Hines RM, Boyd JD, Ko RWY, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA. 2010. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron, 65:178-190.
  9. Nai Q, Li S, Wang S-H, Liu J, Lee FJS, Frankland PW and Liu F. 2010. Uncoupling the D1-NMDA receptor complex impairs NMDA-dependent LTP and working memory. Biological Psychiatry.  67:246-254.
  10. Young BP, Shin JJ, Orij R, Chao JT, Li SC, Guan XL, Khong A, Jan E, Wenk MR, Prinz WA, Smits GJ, and Loewen CJ. 2010. Phosphatidic acid is a pH biosensor that links membrane biogenesis to metabolism. Science 329(5995): 1085-8.
  11. MacVicar BA, Thompson RJ. (2010) Non-junction functions of pannexin-1 channels. Trends in Neuroscience 33(2):93-102.
  12. Mohajerani, M, McVea, DA, Fingas M, and Murphy TH. 2010. Mirrored bilateral slow-wave cortical activity within local circuits revealed by fast bihemispheric voltage-sensitive dye imaging in anesthetized and awake mice. J. Neurosci. 10;30(10):3745-51.
  13. Herrero-Gonzalez S, Giaume C, Naus CC, Medina JM, and Tabernero A. 2010. Connexin43 inhibits the oncogenic activity of c-Src in glioma cells.  Oncogene.
  14. Guttman JA, Lin AE, Li Y, Bechberger J, Naus CC, Vogl AW, and Finlay BB. 2010. Gap junction hemichannels contribute to the generation of diarrhea during infectious enteric disease. Gut 59:218-226.  Epub 2009 Oct. 14.
  15. Naus CC and Laird DW. 2010. Implications and challenges of connexin connections in cancer. Nature Reviews Cancer 10(6):435-441.
  16. Kingwell E, Koch M, Leung B, Isserow S, Geddes J, Rieckmann P, Tremlett H, and the UBC MS Clinic Neurologists. 2010. Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology. 74:1822-1826.
  17. Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, de la Fuente-Fernandez R, Phillips AG, Stoessl AJ. 2010. Great expectations: placebos mimic the effect of active medication in Parkinson’s disease. Arch Gen Psychiatry 67: 857-865.
  18. Stoessl AJ. 2010. Continuous dopaminergic therapy in Parkinson’s disease: time to stride back? Ann Neurol 68: 3-5 (invited editorial).
  19. Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. 2010. New perspectives in the natural history of multiple sclerosis (Review). Neurology. 74:2004-2015.
  20. Simpson S,  Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P & Van der Mei I. 2010. Higher levels of serum 25-hydroxyvitamin D3 are associated with a reduced risk of relapse in multiple sclerosis. Annals of Neurology. 68:193-203.
  21. Vincent, SR. 2010 Nitric oxide neurons and neurotransmission, Prog. Neurobiol. 90: 246-255.
  22. Yuan H, Matthew MS, Stubbs KA, Vocadlo DJ, Davies GJ. 2010. Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J. Am. Chem. Soc. 132:1807-9.
  23. Martin HGS and Wang YT. 2010. Blocking the Deadly Effects of the NMDA Receptor in Stroke. Cell 140:174-176.
  24. Collingridge GL, Peineau S, Howland JG, and Wang YT. 2010. Long-term depression in the CNS. Nature Reviews Neuroscience. 11:459-473.
  25. Dua J, Weia Y, Liu L, Wang Y, Khairovaa R, Blumenthala R, Tragona T, Hunsbergera JG, Machado-Vieiraa R, Drevetsa W, Wang YT, and Manjic HK. 2010. A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors. PNAS. 107:11573–11578.
  26. Migues PV, Hardt O, Wu DC, Gamache K, Sacktor T, Wang YT and Nader K. 2010. PKMζ maintains memories by regulating GluR2-dependent AMPA receptor trafficking. Nature Neuroscience. 13:630-636.
  27. Hellemans KGC, Sliwowska JH, Verma P, Weinberg J. 2010. Prenatal alcohol exposure: Fetal programming and later life vulnerability to stress, depression and anxiety disorders. Neuroscience and Biobehavioral Reviews. 34:791-807.
  28. Valenza M, Leoni V, Karasinska J, Petricca L, Fan J, Carroll J, Pouladi M, Fossale M, Nguyen HP, Riess O, MacDonald M, Wellington C, Di Donato S, Hayden M, Cattaneo E. 2010. Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.  J Neurosci. 11;30(32):10844-10850.
  29. Sun HS, Green TA, Theobald DEH, Birnbaum SG, Graham DL, Zeeb FD, Nestler EJ, Winstanley CA. 2010. Yohimbine increases impulsivity through activation of CREB in the orbitofrontal cortex Biological Psychiatry 67: 649-56.
  30. Green TA, Alibhai IN, Roybal CN, Winstanley CA, Theobald DEH, Birnbaum SG, Graham AR, Unterberg S, Graham DL, Vialou V, Bass CE, Terwilliger EF, Bardo MT, Nestler EJ. 2010. Environmental enrichment produces a behavioral phenotype mediated by low CREB activity in the nucleus accumbens Biological Psychiatry 67: 28-35.
  31. Wang L, He Y, Chen H, Qin W, Fan F, Zhang Y, Wang M, Li K, Zang Y, Woodward TS, Yu C. & Zhu, C. 2010. Dynamic functional reorganization of the motor execution network after stroke. Brain.
  32. Geddes JR, Goodwin GM, Rendell J, Azorin J-M, Young A, et al. 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 375: 385–395.
  33. Liu Y, Wellcome Trust Case Control Consortium (Young A), et al. 2010. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Molecular Psychiatry.
  34. Grozeva D, Wellcome Trust Case Control Consortium (Young A), et al. 2010. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry. 67:318-327.
  35. Wellcome Trust Case Control Consortium (Young A), Craddock N, et al. 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 464: 713-720.
  36. Craddock N, Wellcome Trust Case Control Consortium (Young A), et al. 2010. Strong genetic evidence for a selective influence of GABA(A) receptors on a component of the bipolar disorder phenotype. Mol Psychiatry. 15: 146-153.

Back to top

2009

  1. Eade, KT; Allan, DW. 2009. Neuronal Phenotype in the Mature Nervous System Is Maintained by Persistent Retrograde Bone Morphogenetic Protein Signaling. Journal of Neuroscience. 29(12):3852-3864.
  2. Barton JJS, Hanif H, Ashraf S. 2009. Relating visual to verbal semantic knowledge: the evaluation of object recognition in prosopagnosia. Brain. 132: 3456-66.
  3. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. 2009. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29:11215-11225.
  4. Bombard, Y; Veenstra, G; Friedman, JM; Creighton, S; Currie, L; Paulsen, JS; Bottorff, JL; Hayden, MR. 2009. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. British Medical Journal. 338.
  5. Christoff, K, Gordon, AM, Smallwood, J, Smith, R, & Schooler, JW. 2009.  Experience sampling during fMRI reveals default network and executive system contributions to mind wandering. Proceedings of the National Academy of Sciences, 106 (21), 8719-8724.
  6. Sin, WC; Moniz, DM; Ozog, MA; Tyler, JE; Numata, M; Church, J. 2009. Regulation of Early Neurite Morphogenesis by the Na+/H+ Exchanger NHE1. Journal of Neuroscience. 29(28):8946-8959.
  7. Linhoff, MW; Lauren, J; Cassidy, RM; Dobie, FA; Takahashi, H; Nygaard, HB; Airaksinen, MS; Strittmatter, SM; Craig, AM. 2009. An Unbiased Expression Screen for Synaptogenic Proteins Identifies the LRRTM Protein Family as Synaptic Organizers. Neuron. 61(5):734-749.
  8. Rose, J; Jin, SX; Craig, AM. 2009. Heterosynaptic Molecular Dynamics: Locally Induced Propagating Synaptic Accumulation of CaM Kinase II. Neuron. 61(3):351-358.
  9. Taghibiglou, C; Martin, HGS; Lai, TW; Cho, T; Prasad, S; Kojic, L; Lu, J; Liu, YT; Lo, E; Zhang, S; Wu, JZZ; Li, YP; Wen, YH; Imm, JH; Cynader, MS; Wang, YT. 2009. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nature Medicine. 15(12):1399-0.
  10. McDonald, PC; Dedhar, S; Keller, C. 2009. Integrin-linked kinase: both Jekyll and Hyde in rhabdomyosarcoma. Journal of Clinical Investigation. 119(6):1452-1455.
  11. Fielding, A; Dedhar, S. 2009. The mitotic functions of integrin-linked kinase. Cancer and Metastasis Reviews. 28(40180):99-111.
  12. Akhtar, N; Marlow, R; Lambert, E; Schatzmann, F; Lowe, ET; Cheung, J; Katz, E; Li, WP; Wu, CY; Dedhar, S; Naylor, MJ; Streuli, CH. 2009. Molecular dissection of integrin signalling proteins in the control of mammary epithelial development and differentiation. Development. 136(6):1019-1027.
  13. Kim, SJ; Nian, C; Doudet, DJ; McIntosh, CHS. 2009. Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation. Diabetes. 58(3):641-651.
  14. Jacobs A, Fridman G, Douglas R, Alam N, Latham P, Prusky P, Nirenberg S. 2009. Ruling out and ruling in neural codes.  Proc Natl Acad Sci U S A. 106: 5936-41.
  15. Farrer MJ, Hulihan MM, Kachergus JM, Dachsel J, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol E, Bhatia KP, Wider CW, Vilarino-Guell C, Ross OA, Brown LA, Catanedes-Casey M, Dickson DW, Wszolek ZK. 2009. DCTN1 mutations in Perry syndrome. Nature Genetics 41: 163-165.
  16. Farrer, MJ; Hulihan, MM; Kachergus, JM; Dachsel, JC; Stoessl, AJ; Grantier, LL; Calne, S; Calne, DB; Lechevalier, B; Chapon, F; Tsuboi, Y; Yamada, T; Gutmann, L; Elibol, B; Bhatia, KP; Wider, C; Vilarino-Guell, C; Ross, OA; Brown, LA; Castanedes-Casey, M;. 2009. DCTN1 mutations in Perry syndrome. Nature Genetics. 41(2):163-165.
  17. Ghods-Sharifi S, St Onge JR, Floresco SB. 2009. Fundamental contribution by the basolateral amygdala to different forms of decision making. J Neurosci 29:5251-5259.
  18. Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik D. 2009. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 137:1018-1031.
  19. Liu, XF, Tari, PK, and Haas, K. 2009. PKM zeta restricts dendritic arbor growth by filopodial and branch stabilization within the intact and awake developing brain. Journal of Neuroscience, 29:12229-12235.
  20. Dunfield, D & Haas, K. 2009. Metaplasticity governs natural experience-driven plasticity of nascent embryonic brain circuits. Neuron. 64:240-250.
  21. Haas, K; Sin, WC; Javaherian, A; Li, Z; Cline, HT. 2009. PKM zeta Restricts Dendritic Arbor Growth by Filopodial and Branch Stabilization within the Intact and Awake Developing Brain. Journal of Neuroscience. 29(39):12229-12235.
  22. Haas, K. 2009. Metaplasticity Governs Natural Experience-Driven Plasticity of Nascent Embryonic Brain Circuits. Neuron. 64(2):240-250.
  23. Wiens, MO; Son, WK; Ross, C; Hayden, M; Carleton, B. 2009. Cocaine adulterant linked to neutropenia. Canadian Medical Association Journal. 182(1):57-59.
  24. Warby, SC; Montpetit, A; Hayden, AR; Carroll, JB; Butland, SL; Visscher, F; Collins, JA; Semaka, A; Hudson, TJ; Hayden, MR. 2009. CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup. American Journal of Human Genetics. 84(3):351-366.
  25. Wang, Y; Sternfeld, L; Yang, F; Rodriguez, JA; Ross, C; Hayden, MR; Carriere, F; Liu, G; Hofer, W; Schulz, I. 2009. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut. 58(3):422-430.
  26. Thompson, LM; Aiken, CT; Kaltenbach, LS; Agrawal, N; Illes, K; Khoshnan, A; Martinez-Vincente, M; Arrasate, M; O'Rourke, JG; Khashwji, H; Lukacsovich, T; Zhu, YZ; Lau, AL; Massey, A; Hayden, MR; Zeitlin, SO; Finkbeiner, S; Green, KN; LaFerla, FM; Bates, G. 2009. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. Journal of Cell Biology. 187(7):1083-1099.
  27. Singaraja, RR; Kang, MH; Vaid, K; Sanders, SS; Vilas, GL; Arstikaitis, P; Coutinho, J; Drisdel, RC; El-Husseini, AE; Green, WN; Berthiaume, L; Hayden, MR. 2009. Palmitoylation of ATP-Binding Cassette Transporter A1 Is Essential for Its Trafficking and Function. Circulation Research. 105(2):138-147.
  28. Warby, SC; Visscher, H; Butland, S; Pearson, CE; Hayden, MR. 2009. Haplotype Background, Repeat Length Evolution, and Huntington's Disease Response. American Journal of Human Genetics. 85(6):942-945.
  29. Ross, CJD; Katzov-Eckert, H; Dube, MP; Brooks, B; Rassekh, SR; Barhdadi, A; Feroz-Zada, Y; Visscher, H; Brown, AMK; Rieder, MJ; Rogers, PC; Phillips, MS; Carleton, BC; Hayden, MR. 2009. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature Genetics. 41(12):1345-0.
  30. Xian, XD; Liu, TT; Yu, J; Wang, YH; Miao, YF; Zhang, JJ; Yu, Y; Ross, C; Karasinska, JM; Hayden, MR; Liu, G; Chui, D. 2009. Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice. Journal of Neuroscience. 29(14):4681-4685.
  31. Okamoto, SI; Pouladi, MA; Talantova, M; Yao, DD; Xia, P; Ehrnhoefer, DE; Zaidi, R; Clemente, A; Kaul, M; Graham, RK; Zhang, DX; Chen, HSV; Tong, G; Hayden, MR; Lipton, SA. 2009. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nature Medicine. 15(12):1407-0.
  32. Pouladi, MA; Graham, RK; Karasinska, JM; Xie, YY; Santos, RD; Petersen, A; Hayden, MR. 2009. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain. 132:919-932.
  33. Fan, J; Cowan, CM; Zhang, LYJ; Hayden, MR; Raymond, LA. 2009. Interaction of Postsynaptic Density Protein-95 with NMDA Receptors Influences Excitotoxicity in the Yeast Artificial Chromosome Mouse Model of Huntington's Disease. Journal of Neuroscience. 29(35):10928-10938.
  34. Hayden, MR; Leavitt, BR; Yasothan, U; Kirkpatrick, P. 2009. Tetrabenazine. Nature Reviews Drug Discovery. 8(1):17-18.
  35. Racine, E; Amaram, R; Seidler, M; Karczewska, M; Illes, J. 2009. Media coverage of the persistent vegetative state and end-of-life decision-making Theresa Schiavo’s tragedy and ours, too. Reply. Neurology. 73(11):909-909.
  36. Tairyan, K; Illes, J. 2009. Imaging Genetics: Ethics at the Interface of Research and Clinical Neuroscience. Neurology. 72(11):0-0.
  37. Joshi, PR; Wu, NP; Andre, VM; Cummings, DM; Cepeda, C; Joyce, JA; Carroll, JB; Leavitt, BR; Hayden, MR; Levine, MS; Bamford, NS. 2009. Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease. Journal of Neuroscience. 29(8):2414-2427.
  38. Yeretssian, G; Doiron, K; Shao, W; Leavitt, BR; Hayden, MR; Nicholson, DW; Saleh, M. 2009. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proceedings of the National Academy of Sciences. 106(22):9016-9020.
  39. Gordon, GRJ; Iremonger, KJ; Kantevari, S; Ellis-Davies, GCR; MacVicar, BA; Bains, JS. 2009. Astrocyte-Mediated Distributed Plasticity at Hypothalamic Glutamate Synapses. Neuron. 64(3):391-403.
  40. Brunham, LR; Singaraja, RR; Duong, MN; Timmins, JM; Fievet, C; Bissada, N; Kang, MH; Samra, A; Fruchart, JC; McManus, B; Staels, B; Parks, JS; Hayden, MR. 2009. Tissue-Specific Roles of ABCA1 Influence Susceptibility to Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 29(4):548-554.
  41. MacDonald, MLE; van Eck, M; Hildebrand, RB; Wong, BWC; Bissada, N; Ruddle, P; Kontush, A; Hussein, H; Pouladi, MA; Chapman, MJ; Fievet, C; van Berkel, TJC; Staels, B; McManus, BM; Hayden, MR. 2009. Despite Antiatherogenic Metabolic Characteristics, SCD1-Deficient Mice Have Increased Inflammation and Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 29(3):341-347.
  42. Saab, BJ, Georgiou, J, Nath, A., Lee, FJS, Wang, M, Michalon, A, Liu, F, Mansuy, IM and Roder, JC. 2009. Exploration, Synaptic Plasticity,and Rapid Acquisition of Spatial Memory. Neuron. 63: 643-56.
  43. Miller SP, Ferriero DM. 2009. From Selective Vulnerability To Connectivity: Insights From Newborn Brain Imaging. Trends Neurosci. 32(9):496-505.
  44. Chau V, Poskitt KJ, McFadden DE, Bowen-Roberts T, Synnes A, Brant R, Sargent MA, Soulikias W, Miller SP. 2009. Effect of chorioamnionitis on brain development and injury in premature newborns. Annals of Neurology. 66(2):155-64.
  45. Chopra, N; Yang, T; Asghari, P; Moore, ED; Huke, S; Akin, B; Cattolica, RA; Perez, CF; Hlaing, T; Knollmann-Ritschel, BEC; Jones, LR; Pessah, IN; Allen, PD; Franzini-Armstrong, C; Knollmann, BC. 2009. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proceedings of the National Academy of Sciences. 106(18):7636-7641.
  46. Winship IR, Murphy TH. 2009. Remapping the somatosensory cortex after stroke: insight from imaging the synapse to network. Neuroscientist 15:507-524.
  47. Ayling, OGS; Harrison, TC; Boyd, JD; Goroshkov, A; Murphy, TH. 2009. Automated light-based mapping of motor cortex by photoactivation of channelrhodopsin-2 transgenic mice. Nature Methods. 6(3):219-224.
  48. Brown, CE; Aminoltejari, K; Erb, H; Winship, IR; Murphy, TH. 2009. In Vivo Voltage-Sensitive Dye Imaging in Adult Mice Reveals That Somatosensory Maps Lost to Stroke Are Replaced over Weeks by New Structural and Functional Circuits with Prolonged Modes of Activation within Both the Peri-Infarct Zone and Distant Sites. Journal of Neuroscience. 29(6):1719-1734.
  49. Murphy, TH; Corbett, D. 2009. Plasticity during stroke recovery: from synapse to behaviour. Nature Reviews Neuroscience. 10(12):861-872.
  50. Sigler, A; Mohajerani, MH; Murphy, TH. 2009. Imaging rapid redistribution of sensory-evoked depolarization through existing cortical pathways after targeted stroke in mice. Proceedings of the National Academy of Sciences. 106(28):11759-11764.
  51. Xiao C, Nashmi R, McKinney S, Cai H, Michael McIntosh MJ, Lester HA. 2009. Chronic nicotine selectively enhances α4β2 nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29: 12428-39.
  52. Decrock, E; De Vuyst, E; Vinken, M; Van Moorhem, M; Vranckx, K; Wang, N; Van Laeken, L; De Bock, M; D'Herde, K; Lai, CP; Rogiers, V; Evans, WH; Naus, CC; Leybaert, L. 2009. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death and Differentiation. 16(1):151-163.
  53. Cina, C; Maass, K; Theis, M; Willecke, K; Bechberger, JF; Naus, CC. 2009. Involvement of the Cytoplasmic C-Terminal Domain of Connexin43 in Neuronal Migration. Journal of Neuroscience. 29(7):2009-2021.
  54. Lai, CPK; Bechberger, JF; Naus, CC. 2009. Pannexin2 as a novel growth regulator in C6 glioma cells. Oncogene. 28(49):4402-4408.
  55. Mingorance-Le Meur, A; O'Connor, TP. 2009. Neurite consolidation is an active process requiring constant repression of protrusive activity. EMBO Journal. 28(3):248-260.
  56. Barnes, MG; Grom, AA; Thompson, SD; Griffin, TA; Pavlidis, P; Itert, L; Fall, N; Sowders, DP; Hinze, CH; Aronow, BJ; Luyrink, LK; Srivastava, S; Ilowite, NT; Gottlieb, BS; Olson, JC; Sherry, DD; Glass, DN; Colbert, RA. 2009. Subtype-Specific Peripheral Blood Gene Expression Profiles in Recent-Onset Juvenile Idiopathic Arthritis. Arthritis and Rheumatism. 60(7):2102-2112.
  57. Griffin, TA; Barnes, MG; Ilowite, NT; Olson, JC; Sherry, DD; Gottlieb, BS; Aronow, BJ; Pavlidis, P; Hinze, CH; Thornton, S; Thompson, SD; Grom, AA; Colbert, RA; Glass, DN. 2009. Gene Expression Signatures in Polyarticular Juvenile Idiopathic Arthritis Demonstrate Disease Heterogeneity and Offer a Molecular Classification of Disease Subsets. Arthritis and Rheumatism. 60(7):2113-2123.
  58. Ware, CB; Wang, LL; Mecham, BH; Shen, LL; Nelson, AM; Bar, M; Lamba, DA; Dauphin, DS; Buckingham, B; Askari, B; Lim, R; Tewari, M; Gartler, SM; Issa, JP; Pavlidis, P; Duan, ZJ; Blau, CA. 2009. Histone Deacetylase Inhibition Elicits an Evolutionarily Conserved Self-Renewal Program in Embryonic Stem Cells. Cell Stem Cell. 4(4):359-369.
  59. Graham, RK; Pouladi, MA; Joshi, P; Lu, G; Deng, Y; Wu, NP; Figueroa, BE; Metzler, M; Andre, VM; Slow, EJ; Raymond, L; Friedlander, R; Levine, MS; Leavitt, BR; Hayden, MR. 2009. Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease. Journal of Neuroscience. 29(7):2193-2204.
  60. Koch M, Kingwell E, Rieckmann P and Tremlett H and the UBC Neurologists. 2009. The natural history of primary progressive MS. Neurology. 73 1996-2002.
  61. Nandhagopal, R; Kuramoto, L; Schulzer, M; Mak, E; Cragg, J; Lee, CS; McKenzie, J; McCormick, S; Samii, A; Troiano, A; Ruth, TJ; Sossi, V; de la Fuente-Fernandez, R; Calne, DB; Stoessl, AJ. 2009. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain. 132:2970-2979.
  62. Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, Lee CS, McKenzie J, McCormick S, Samii A, Troiano A, Ruth TJ, Sossi V, de la Fuente-Fernandez R, Calne DB, Stoessl AJ. 2009. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 132: 2970-2979.
  63. Van Raamsdonk, CD; Bezrookove, V; Green, G; Bauer, J; Gaugler, L; O'Brien, JM; Simpson, EM; Barsh, GS; Bastian, BC. 2009. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 457(7229):599-0.
  64. Zamponi, GW; Lewis, RJ; Todorovic, SM; Arneric, SP; Snutch, TP. 2009. Role of voltage-gated calcium channels in ascending pain pathways. Brain Research Reviews. 60(1):84-89.
  65. Hildebrand, ME; Isope, P; Miyazaki, T; Nakaya, T; Garcia, E; Feltz, A; Schneider, T; Hescheler, J; Kano, M; Sakimura, K; Watanabe, M; Dieudonne, S; Snutch, TP. 2009. Functional Coupling between mGluR1 and Ca(v)3.1 T-Type Calcium Channels Contributes to Parallel Fiber-Induced Fast Calcium Signaling within Purkinje Cell Dendritic Spines. Journal of Neuroscience. 29(31):9668-9682.
  66. Powell, KL; Cain, SM; Ng, C; Sirdesai, S; David, LS; Kyi, M; Garcia, E; Tyson, JR; Reid, CA; Bahlo, M; Foote, SJ; Snutch, TP; O'Brien, TJ. 2009. A Ca(v)3.2 T-Type Calcium Channel Point Mutation Has Splice-Variant-Specific Effects on Function and Segregates with Seizure Expression in a Polygenic Rat Model of Absence Epilepsy. Journal of Neuroscience. 29(2):371-380.
  67. Wang, LJ; Zis, O; Ma, GX; Shan, ZX; Zhang, X; Wang, S; Dai, CB; Zhao, JH; Lin, QX; Lin, SG; Song, WH. 2009. Upregulation of Macrophage Migration Inhibitory Factor Gene Expression in Stroke. Stroke. 40(3):973-976.
  68. Troiano, AR; de la Fuente-Fernandez, R; Sossi, V; Schulzer, M; Mak, E; Ruth, TJ; Stoessl, AJ. 2009. PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology. 72(14):1211-1216.
  69. Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y and the UBC Neurologists. 2009. The impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 73:1616-1623.
  70. Franklin, G and Tremlett H. 2009. Multiple sclerosis and pregnancy: What should we be telling our patients? (Editorial) Neurology. 73(22):1820-2.
  71. Stubbs, KA, Macauley, MS, Vocadlo, DJ. 2009. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells. Angew. Chem. Int. Ed. Engl. 48:1300-1303.
  72. Marcelo, F, He, Y, Yuzwa, SA, Nieto, L, Jiménez-Barbero, J, Sollogoub, M, Vocadlo, DJ, Davies, GD, Blériot, Y. 2009. Molecular Basis for Inhibition of GH84 Glycoside Hydrolases by Substituted Azepanes: Conformational Flexibility Enables Probing of Substrate Distortion. J. Am. Chem. Soc. 131:5390-5392.
  73. Sinclair, DAR., Syrzycka, M, Macauley, MS, Rastgardani, T, Komljenovic, I., Vocadlo, DJ, Brock, HW, Honda, BM. 2009. Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc. Natl. Acad. Sci. USA. 106:13427-13433.
  74. Greig, IR, Macauley,  MS, Williams IH, Vocadlo, DJ. 2009. Probing Synergy between Two Catalytic Strategies in the Glycoside Hydrolase O-GlcNAcase Using Multiple Linear Free Energy Relationships J. Am. Chem. Soc. 131:13415-13422.
  75. Ryu, JK; Cho, T; Choi, HB; Wang, YT; McLarnon, JG. 2009. Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology. Journal of Neuroscience. 29(1):3-13.
  76. Karasinska, JM; Rinninger, F; Lutjohann, D; Ruddle, P; Franciosi, S; Kruit, JK; Singaraja, RR; Hirsch-Reinshagen, V; Fan, J; Brunham, LR; Bissada, N; Ramakrishnan, R; Wellington, CL; Parks, JS; Hayden, MR. 2009. Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function. Journal of Neuroscience. 29(11):3579-3589.

Back to top

2008

  1. Ahern, CA; Eastwood, AL; Dougherty, DA; Horn, R. 2008. Electrostatic contributions of aromatic residues in the local anesthetic receptor of voltage-gated sodium channels. Circulation Research. 102(1):86-94.
  2. Lee, SH; Peng, IF; Ng, YG; Yanagisawa, M; Bamji, SX; Elia, LP; Balsamo, J; Lilien, J; Anastasiadis, PZ; Ullian, EM; Reichardt, LF. 2008. Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway mediated by p120catenin, Fer, SHP-2, and beta-catenin. Journal of Cell Biology. 183(5):893-908.
  3. Polli FE, Barton JJS, Thakkar KN, Cain MS, Goff DC, Rauch SL, Manoach DS. 2008. Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia. Brai. 131: 971-86.
  4. Thakkar KN, Polli FE, Joseph RM, Tuch DS, Hadjikhani N, Barton JJS, Manoach DS. 2008. Response monitoring, repetitive behavior, and anterior cingulate abnormalities in autism spectrum disorders. Brain. 131: 2464-78.
  5. Rutherford, NJ; Zhang, YJ; Baker, M; Gass, JM; Finch, NA; Xu, YF; Stewart, H; Kelley, BJ; Kuntz, K; Crook, RJP; Sreedharan, J; Vance, C; Sorenson, E; Lippa, C; Bigio, EH; Geschwind, DH; Knopman, DS; Mitsumoto, H; Petersen, RC; Cashman, NR; Hutton, M; Shaw. 2008. Novel Mutations in TARDBP(TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis. PLOS Genetics. 4(9):e1000193-.
  6. Velde, CV; Miller, TM; Cashman, NR; Cleveland, DW. 2008. Selective assoction of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proceedings of the National Academy of Sciences. 105(10):4022-4027.
  7. Kerschensteiner D, Liu H, Cheng CW, Demas J, Cheng SH, Hui CC, Chow RL, Wong ROL. 2008. Genetic control of circuit function: Vsx1 and Irx5 transcription factors regulate contrast adaptation in the mouse retina. Journal of Neuroscience, 28(10):2342-52.
  8. Tucker, KL; Sage, T; Stevens, JM; Jordan, PA; Jones, S; Barrett, NE; St-Arnaud, R; Frampton, J; Dedhar, S; Gibbins, JM. 2008. A dual role for integrin-linked kinase in platelets: regulating integrin function and alpha-granule secretion. Blood. 112(12):4523-4531.
  9. McDonald, PC; Oloumi, A; Mills, J; Dobreva, I; Maidan, M; Gray, V; Wederell, ED; Bally, MB; Foster, LJ; Dedhar, S. 2008. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Research. 68(6):1618-1624.
  10. Assi, K; Mills, J; Owen, D; Ong, C; St Arnaud, R; Dedhar, S; Salh, B. 2008. Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis. Gut. 57(7):931-940.
  11. Guo, SZ; Kim, WJ; Lok, J; Lee, SR; Besancon, E; Luo, BH; Stins, MF; Wang, XY; Dedhar, S; Lo, EH. 2008. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proceedings of the National Academy of Sciences. 105(21):7582-7587.
  12. Gkretsi, V; Apte, U; Mars, WM; Bowen, WC; Luo, JH; Yang, Y; Yu, YP; Orr, A; St-Arnaud, R; Dedhar, S; Kaestner, KH; Wu, C; Michalopoulos, GK. 2008. Liver-Specific Ablation of Integrin-Linked Kinase in Mice Results in Abnormal Histology, Enhanced Cell Proliferation, and Hepatomegaly. Hepatology. 48(6):1932-1941.
  13. Fielding, AB; Dobreva, I; McDonald, PC; Foster, LJ; Dedhar, S. 2008. Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. Journal of Cell Biology. 180(4):681-689.
  14. Diamond, A & Amso, D. 2008.  Contributions of neuroscience to our understanding of cognitive development.  Current Directions in Psychological Science, 17, 136-141.
  15. Diamond, A. 2008. Minding controls in curriculum study - Response. Science. 319(5867):1185-1186.
  16. Kim, SJ; Nian, C; Doudet, DJ; McIntosh, CHS. 2008. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes. 57(5):1331-1339.
  17. Prusky GT, Silver BD, Tchetter WW, Alam NM, Douglas, RM. 2008. Experience-dependent plasticity from eye-opening enables lasting, visual-cortex dependent enhancement of motion vision.  Journal of Neuroscience, 28(39) 9817-27.
  18. Rademakers, R; Eriksen, JL; Baker, M; Robinson, T; Ahmed, Z; Lincoln, SJ; Finch, N; Rutherford, NJ; Crook, RJ; Josephs, KA; Boeve, BF; Knopman, DS; Petersen, RC; Parisi, JE; Caselli, RJ; Wszolek, ZK; Uitti, RJ; Feldman, H; Hutton, ML; Mackenzie, IR; Graff. 2008. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Molecular Genetics. 17(23):3631-3642.
  19. Gauthier, S; Dubois, B; Feldman, H; Scheltens, P. 2008. Revised research diagnostic criteria for Alzheimer's disease. Lancet Neurology. 7(8):668-670.
  20. Winblad, B; Gauthier, S; Scinto, L; Feldman, H; Wilcock, GK; Truyen, L; Mayorga, AJ; Wang, D; Brashear, HR; Nye, JS. 2008. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology. 70(22):2024-2035.
  21. Feldman, HH; Jacova, C; Robillard, A; Garcia, A; Chow, T; Borrie, M; Schipper, HM; Blair, M; Kertesz, A; Chertkow, H. 2008. Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal. 178(7):825-836.
  22. Moosajee M, Gregory-Evans K, Ellis CD, Seabra MC, Gregory-Evans CY. 2008. Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Human Molecular Genetics.17:3987-4000.
  23. Wang, CE; Tydlacka, S; Orr, AL; Yang, SH; Graham, RK; Hayden, MR; Li, SH; Chan, AWS; Li, XJ. 2008. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Human Molecular Genetics. 17(17):2738-2751.
  24. Warby, SC; Doty, CN; Graham, RK; Carroll, JB; Yang, YZ; Singaraja, RR; Overall, CM; Hayden, MR. 2008. Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus. Human Molecular Genetics. 17(15):2390-2404.
  25. Wang Y, Sternfeld L, Yang F, Rodriguez JA, Ross C, Hayden MR, Carriere F, Liu G, Hofer W, Schulz I. 2008. Enhanced susceptibility to pancreatitis in severe hypertriglyceridemic lipoprotein lipase deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut. 195(1):13-28.
  26. Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X, Fan J, Ross C, Karansinska J, Hayden MR, Liu G. 2008. Spontaneous Atherosclerosis in Aged Lipoprotein Lipase Deficient Mice with Severe Hypertriglyceridemia on a Normal Chow Diet. Circ. Res. 102(2):250-6.
  27. Liu, G; Hayden, MR. 2008. Is LPL deficiency atherogenic? Response. Circulation Research. 102(11):E119-E119.
  28. Zhang, XH; Qi, R; Xian, XD; Yang, F; Blackstein, M; Deng, XM; Fan, JL; Ross, C; Karasinska, J; Hayden, MR; Liu, G. 2008. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circulation Research. 102(2):250-256.
  29. Brunham, LR; Kastelein, JJP; Hayden, MR. 2008. ABCA1 Gene Mutations, HDL Cholesterol Levels, and Risk of Ischemic Heart Disease. Journal of the American Medical Association. 300(17):1997-1998.
  30. Brunham, LR; Kruit, JK; Verchere, CB; Hayden, MR. 2008. Cholesterol in islet dysfunction and type 2 diabetes. Journal of Clinical Investigation. 118(2):403-408.
  31. Bjorkqvist, M; Wild, EJ; Thiele, J; Silvestroni, A; Andre, R; Lahiri, N; Raibon, E; Lee, RV; Benn, CL; Soulet, D; Magnusson, A; Woodman, B; Landles, C; Pouladi, MA; Hayden, MR; Khalili-Shirazi, A; Lowdell, MW; Brundin, P; Bates, GP; Leavitt, BR; Moller, T. 2008. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. Journal of Experimental Medicine. 205(8):1869-1877.
  32. Cowan, CM; Fan, MMY; Fan, J; Shehadeh, J; Zhang, LYJ; Graham, RK; Hayden, MR; Raymond, LA. 2008. Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity. Journal of Neuroscience. 28(48):12725-12735.
  33. Illes, J. 2008. Brain screening and incidental findings: flocking to folly? Lancet Neurology. 7(1):23-24.
  34. Pierce, R; Illes, J. 2008. Policy must recognize drug impact on different sectors. Nature. 451(7178):521-521.
  35. Illes, J; Kirschen, MP; Edwards, E; Bandettini, P; Cho, MK; Ford, PJ; Glover, GH; Kulynych, J; Macklin, R; Michael, DB; Wolf, SM; Grabowski, T; Seto, B. 2008. Practical approaches to incidental findings in brain imaging research. Neurology. 70(5):384-390.
  36. Racine, E; Amaram, R; Seidler, M; Karczewska, M; Illes, J. 2008. Media coverage of the persistent vegetative state and end-of-life decision-making. Neurology. 71(13):1027-1032.
  37. Illes, J. 2008. Fixing the leaky faucet. Science. 321(5897):1776-1776.
  38. Lee, ST; Chu, K; Jung, KH; Kim, SJ; Kim, DH; Kang, KM; Hong, NH; Kim, JH; Ban, JJ; Park, HK; Kim, SU; Park, CG; Lee, SK; Kim, M; Roh, JK. 2008. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain. 131:616-629.
  39. Wang, HK; Park, UJ; Kim, SY; Lee, JH; Kim, SU; Gwag, BJ; Lee, YB. 2008. Free radical production in CA1 neurons induces MIP-1 alpha expression, microglia recruitment, and delayed neuronal death after transient forebrain ischemia. Journal of Neuroscience. 28(7):1721-1727.
  40. Hara, K; Yasuhara, T; Maki, M; Matsukawa, N; Masuda, T; Yu, SJ; Ali, M; Yu, GL; Xu, L; Kim, SU; Hess, DC; Borlongan, CV. 2008. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Proceedings of the National Academy of Sciences. 85(3):318-334.
  41. Gutova, M; Najbauer, J; Frank, RT; Kendall, SE; Gevorgyan, A; Metz, MZ; Guevorkian, M; Edmiston, M; Zhao, D; Glackin, CA; Kim, SU; Aboody, KS. 2008. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells. 26(6):1406-1413.
  42. Kendall, SE; Najbauer, J; Johnston, HF; Metz, MZ; Li, S; Bowers, M; Garcia, E; Kim, SU; Barish, ME; Aboody, KS; Glackin, CA. 2008. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells. 26(6):1575-1586.
  43. Wang, H, Wu, L-J, Kim, SS, Lee, FJS, Gong, B, Toyoda, H, Ren, M, Xu, H, Liu, F, Zhao, M-G and Zhuo, M. 2008. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59: 634-7.
  44. Gordon, GRJ; Choi, HB; Rungta, RL; Ellis-Davies, GCR; MacVicar, BA. 2008. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature. 456(7223):745-U45.
  45. Kisilevsky, AE; Mulligan, SJ; Altier, C; Iftinca, MC; Varela, D; Tai, C; Chen, L; Hameed, S; Hamid, J; MacVicar, BA; Zamponi, GW. 2008. D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry. Neuron. 58(4):557-570.
  46. Thompson, RJ; Jackson, MF; Olah, ME; Rungta, RL; Hines, DJ; Beazely, MA; MacDonald, JF; MacVicar, BA. 2008. Activation of Pannexin-1 Hemichannels Augments Aberrant Bursting in the Hippocampus. Science. 322(5907):1555-1559.
  47. Nandhagopal, R; McKeown, MJ; Stoessl, AJ. 2008. Invited article: Functional imaging in Parkinson disease. Neurology. 70(16):1478-1488.
  48. Kwok, MCM; Holopainen, JM; Molday, LL; Foster, LJ; Molday, RS. 2008. Proteomics of photoreceptor outer segments identifies a subset of SNARE and Rab proteins implicated in membrane vesicle trafficking and fusion. Molecular & Cellular Proteomics. 7(6):1053-1066.
  49. Togashi, K; von Schimmelmann, MJ; Nishiyama, M; Lim, CS; Yoshida, N; Yun, B; Molday, RS; Goshima, Y; Hong, K. 2008. Cyclic GMP-gated CNG channels function in Sema3A-induced growth cone repulsion. Neuron. 58(5):694-707.
  50. Brown CE, and Murphy TH. 2008. Livin’ on the Edge: Imaging Dendritic Spine Turnover in the Peri-Infarct Zone during Ischemic Stroke and Recovery.  The Neuroscientist 14:139-46.
  51. Li, P; Murphy, TH. 2008. Two-Photon Imaging during Prolonged Middle Cerebral Artery Occlusion in Mice Reveals Recovery of Dendritic Structure after Reperfusion. Journal of Neuroscience. 28(46):11970-11979.
  52. Murphy, TH; Li, P; Betts, K; Liu, R. 2008. Two-photon Imaging of stroke onset in vivo reveals that NMDA-receptor independent ischemic depolarization is the major cause of rapid reversible damage to dendrites and spines. Journal of Neuroscience. 28(7):1756-1772.
  53. Winship, IR; Murphy, TH. 2008. In vivo calcium imaging reveals functional rewiring of single somatosensory neurons after stroke. Journal of Neuroscience. 28(26):6592-6606.
  54. Decrock E, De Vuyst E, Vinken M, Van Moorhem M, Vranckx K, Wang N, Van Laeken L, De Bock M, D'Herde K, Lai CP, Rogiers V, Evans WH, Naus CC, Leybaert L. 2008. Connexin43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death & Differentiation 16:151-163.
  55. Oberlander, TF; Bonaguro, RJ; Misri, S; Papsdorf, M; Ross, CJD; Simpson, EM. 2008. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Molecular Psychiatry. 13(1):65-73.
  56. Stark, KL; Xu, B; Bagchi, A; Lai, WS; Liu, H; Hsu, R; Wan, X; Pavlidis, P; Mills, AA; Karayiorgou, M; Gogos, JA. 2008. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics. 40(6):751-760.
  57. Durstewitz, D; Seamans, JK. 2008. The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia. Biological Psychiatry. 64(9):739-749.
  58. Lapish, CC; Durstewitz, D; Chandler, LJ; Seamans, JK. 2008. Successful choice behavior is associated with distinct and coherent network states in anterior cingulate cortex. Proceedings of the National Academy of Sciences. 105(33):11963-11968.
  59. Seamans JK. 2008. Losing Inhibition with Ketamine. Nature Chemical Biology 4, 91-93.
  60. Newton, PM; Zeng, L; Wang, V; Connolly, J; Wallace, MJ; Kim, C; Shin, HS; Belardetti, F; Snutch, TP; Messing, RO. 2008. A Blocker of N- and T-type Voltage-Gated Calcium Channels Attenuates Ethanol-Induced Intoxication, Place Preference, Self-Administration, and Reinstatement. Journal of Neuroscience. 28(45):11712-11719.
  61. Qing, H; He, GQ; Ly, PTT; Fox, CJ; Staufenbiel, M; Cai, F; Zhang, ZH; Wei, SC; Sun, XL; Chen, CH; Zhou, WH; Wang, K; Song, WH. 2008. Valproic acid inhibits A beta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. Journal of Experimental Medicine. 205(12):2781-2789.
  62. Nandhagopal, R; Mak, E; Schulzer, M; McKenzie, J; McCormick, S; Sossi, V; Ruth, TJ; Strongosky, A; Farrer, MJ; Wszolek, ZK; Stoessl, AJ. 2008. Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study. Neurology. 71(22):1790-1795.
  63. Marks, WJ; Ostrem, JL; Verhagen, L; Starr, PA; Larson, PS; Bakay, RAE; Taylor, R; Cahn-Weiner, DA; Stoessl, AJ; Olanow, CW; Bartus, RT. 2008. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurology. 7(5):400-408.
  64. Lewitt PA, Guttman M, Tetrud JW, Tuite PJ, Mori A, Chaikin P, Sussman NM; 6002-US-005 Study Group (Stoessl, AJ) 2008. Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces off time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann. Neurol. 63: 295-302.
  65. Martin, WR; Wieler, M; Stoessl, AJ; Schulzer, M. 2008. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease. Annals of Neurology. 63(3):388-394.
  66. Ficko-Blean, E, Stubbs, KA, Berg, O, Vocadlo, DJ, and Boraston, AB. 2008. Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.  Proc. Natl. Acad. Aci. USA. 105:6560-6565.
  67. Martinez-Fleites, C, Macauley, MS, He, Y, Shen, DA, Vocadlo, DJ and Davies, GJ. 2008. Structure of an O-GlcNAc transferase homologue provides insight into intracellular glycosylation. Nat. Struct. Mol. Biol. 15:764-765.
  68. Yuzwa, SA., Macauley, MS, Heinonen, JE, Shan, X, Dennis, RJ, He, Y, Whitworth, GE, Stubbs, KS, McEachern, E, Davies, G, Vocadlo, DJ. 2008. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of Tau in vivo. Nat. Chem. Biol. 4:483-490.
  69. Werker, JF, & Byers-Heinlein, K. 2008. Bilingualism in infancy: First steps in perception and comprehension of language. Trends in Cognitive Sciences. 12(4):144-151.
  70. Ferreira, MA, Wellcome Trust Case Control Consortium (Young, A), et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 40: 1056-1058.
  71. Barrett JC, Wellcome Trust Case Control Consortium (Young, A), et al. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40: 955-962.
  72. Weedon MN, Wellcome Trust Case Control Consortium (Young, A), et al. 2008. Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 40: 575-583.
  73. Zeggini E, Wellcome Trust Case Control Consortium (Young, A), et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40: 638-645.
  74. Sandhu MS, Wellcome Trust Case Control Consortium (Young, A), et al. 2008. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 371: 483-491.
  75. Loos RJ, Wellcome Trust Case Control Consortium (Young, A), et al. 2008. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 40: 768-775.
  76. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, Nimmo ER, Massey D, Berzuini C, Johnson C, Barrett JC, Cummings FR, Drummond H, Lees CW, Onnie CM, Hanson CE, Blaszczyk K, Inouye M, Ewels P, Ravindrarajah R, Keniry A, Hunt S, Carter M, Watkins N, Ouwehand W, Lewis CM, Cardon L; Wellcome Trust Case Control Consortium (Young, A), Lobo A, Forbes A, Sanderson J, Jewell DP, Mansfield JC, Deloukas P, Mathew CG, Parkes M, Satsangi J. 2008. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet. 40: 710-712.

Back to top




Print this page

Right Column Image